ORIC Pharmaceuticals Past Earnings Performance
Past criteria checks 0/6
ORIC Pharmaceuticals's earnings have been declining at an average annual rate of -19.1%, while the Biotechs industry saw earnings growing at 7.7% annually.
Key information
-19.1%
Earnings growth rate
45.6%
EPS growth rate
Biotechs Industry Growth | -14.6% |
Revenue growth rate | n/a |
Return on equity | -43.7% |
Net Margin | n/a |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How ORIC Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 0 | -120 | 28 | 107 |
30 Jun 24 | 0 | -111 | 27 | 98 |
31 Mar 24 | 0 | -102 | 26 | 88 |
31 Dec 23 | 0 | -101 | 26 | 85 |
30 Sep 23 | 0 | -93 | 24 | 77 |
30 Jun 23 | 0 | -93 | 24 | 69 |
31 Mar 23 | 0 | -90 | 25 | 64 |
31 Dec 22 | 0 | -89 | 25 | 62 |
30 Sep 22 | 0 | -91 | 25 | 62 |
30 Jun 22 | 0 | -85 | 25 | 60 |
31 Mar 22 | 0 | -85 | 24 | 62 |
31 Dec 21 | 0 | -79 | 22 | 57 |
30 Sep 21 | 0 | -84 | 20 | 52 |
30 Jun 21 | 0 | -91 | 18 | 48 |
31 Mar 21 | 0 | -81 | 16 | 40 |
31 Dec 20 | 0 | -74 | 13 | 36 |
30 Sep 20 | 0 | -54 | 11 | 31 |
30 Jun 20 | 0 | -35 | 9 | 28 |
31 Mar 20 | 0 | -30 | 7 | 25 |
31 Dec 19 | 0 | -27 | 6 | 23 |
31 Dec 18 | 0 | -21 | 3 | 19 |
Quality Earnings: 4TZ is currently unprofitable.
Growing Profit Margin: 4TZ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4TZ is unprofitable, and losses have increased over the past 5 years at a rate of 19.1% per year.
Accelerating Growth: Unable to compare 4TZ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4TZ is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-18.2%).
Return on Equity
High ROE: 4TZ has a negative Return on Equity (-43.75%), as it is currently unprofitable.